These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 18361932)
1. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932 [TBL] [Abstract][Full Text] [Related]
2. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Tamaki S; Kawakami M; Yamanaka Y; Shimomura H; Imai Y; Ishida J; Yamamoto K; Ishitani A; Hatake K; Kirita T Clin Immunol; 2009 Mar; 130(3):331-7. PubMed ID: 18951065 [TBL] [Abstract][Full Text] [Related]
3. Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma. Tamaki S; Kawakami M; Ishitani A; Kawashima W; Kasuda S; Yamanaka Y; Shimomura H; Imai Y; Nakagawa Y; Hatake K; Kirita T Anticancer Res; 2010 Oct; 30(10):4097-101. PubMed ID: 21036725 [TBL] [Abstract][Full Text] [Related]
4. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ; Li JR; Li ZB Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [TBL] [Abstract][Full Text] [Related]
5. [Soluble major histocompatibility complex class I-related chain A in sera of patients with oral squamous cell carcinoma]. Li C; Shi F; Yang D; Wang J; Jian X; Jiang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):168-72. PubMed ID: 22561434 [TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma. Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324 [TBL] [Abstract][Full Text] [Related]
8. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897 [TBL] [Abstract][Full Text] [Related]
9. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Rebmann V; Schütt P; Brandhorst D; Opalka B; Moritz T; Nowrousian MR; Grosse-Wilde H Clin Immunol; 2007 Apr; 123(1):114-20. PubMed ID: 17218152 [TBL] [Abstract][Full Text] [Related]
11. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853 [TBL] [Abstract][Full Text] [Related]
12. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral lymphangiogenesis in oral squamous cell carcinoma and its clinicopathological significance. Zhao D; Pan J; Li XQ; Wang XY; Tang C; Xuan M J Oral Pathol Med; 2008 Nov; 37(10):616-25. PubMed ID: 19012622 [TBL] [Abstract][Full Text] [Related]
14. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma. Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737 [TBL] [Abstract][Full Text] [Related]
15. MICA and MICB overexpression in oral squamous cell carcinoma. Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and CD34 expression as a predictor of recurrence in oral squamous cell carcinoma. Kademani D; Lewis JT; Lamb DH; Rallis DJ; Harrington JR J Oral Maxillofac Surg; 2009 Sep; 67(9):1800-5. PubMed ID: 19686913 [TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573 [TBL] [Abstract][Full Text] [Related]